CClinicalTrials.gg
Sign In
CompletedNCT04074070EchoPsoUpdated Mar 16, 2023

Prevalence of Sonographic Abnormalities of Joints and Entheses in Psoriasis Patients With or Without Musculoskeletal Complains

An observational study in Psoriasis, sponsored by Assistance Publique - Hôpitaux de Paris. Completed at 1 site in France. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2023-03-16.

Sponsored by Assistance Publique - Hôpitaux de Paris · Observational

Study type
Observational
Model
Case-control
Time perspective
Cross-sectional
Enrollment
25
Ages
18 Years and older
Sex
All
01

Study summary

The objectives of this study are:

  • to estimate the prevalence and severity of inflammatory (synovitis, tenosynovitis, enthesitis, dactylitis) and structural (erosions, osteophytes, enthesophytes, cortical irregularities ) ultrasound lesions in psoriasis patients with or without related musculoskeletal symptoms;
  • to compare them to healthy subjects or patients suffering from rheumatoid arthritis and osteoarthritis.
02

Conditions studied

  • Psoriasis

Browse trials for

Keywords

  • psoriasis
  • psoriatic arthritis
  • ultrasound
03

In context

Psoriasis

1,899 studies on the registry are indexed under Psoriasis; 233 are open to participants now.

This study's enrollment of 25 is below the median of 200 across 396 observational studies indexed under Psoriasis.

Browse Psoriasis studies →

Lead sponsor

Assistance Publique - Hôpitaux de Paris is the lead sponsor of 3,505 studies on the registry; 1,006 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

Adult patients consulting the dermatology department of Ambroise Paré hospital for cutaneous psoriasis between September 2019 and December 2020.

Inclusion criteria

  • Age ≥ 18 years;
  • Psoriasis diagnosed by a dermatologist;
  • Able to participate in the study;
  • Informed consent signed.

Exclusion criteria

Exclusion Criteria:

  • Chronic disease likely to cause musculoskeletal symptoms (connective tissue diseases, inflammatory bowel diseases, overload disorders, crystal related arthritis, septic arthritis...).
05

Study design

Observational model
Case-control
Time perspective
Cross-sectional
Enrollment
25 participants (actual)
Patient registry
No

Groups and cohorts

  • Psoriasis with and without musculoskeletal complains

    psoriasis with and without musculoskeletal complains

    Other: Ultrasound examination

  • Healthy individuals

    Other: Ultrasound examination

  • Psoriatic arthritis

    Other: Ultrasound examination

Interventions

  • OtherUltrasound examination

    Ultrasound examination of joints, tendons and entheses.

06

What researchers measure

Primary outcomes

  1. synovitis

    Number and percentage, N (%) of patients with at least one synovitis.

    Time frame: through study completion, an average of 1 year

  2. enthesitis

    N (%) of patients with at least one ultrasound enthesitis.

    Time frame: through study completion, an average of 1 year

  3. joint erosion

    N (%) of patients with at least one joint erosion.

    Time frame: through study completion, an average of 1 year

  4. osteophyte/ cortical irregularity

    N (%) of patients with at least one osteophyte/ cortical irregularity.

    Time frame: through study completion, an average of 1 year

  5. enthesophyte

    N (%) of patients with at least one enthesophyte.

    Time frame: through study completion, an average of 1 year

07

Study locations

1 site
  • Rheumatology Department, Ambroise Paré Hospital
    Boulogne-Billancourt, 92100, France
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Mar 16, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT04074070
Lead sponsor
Assistance Publique - Hôpitaux de Paris
Responsible party
Sponsor
First posted
Aug 29, 2019
Start date
Feb 18, 2020
Primary completion
Sep 30, 2020
Completion
Sep 30, 2020
Last update
Mar 16, 2023

Study contacts

Maria-Antonietta D'Agostino, MD, PhD
principal investigator · Rheumatology Department, Ambroise Paré Hospital

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Mar 2023. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Other studies in this condition

Psoriasis→

Other studies from this sponsor

Assistance Publique - Hôpitaux de Paris

Start the discussion